You are here
HHS SBIR PHS2015-1
Agency:
Department of Health and Human Services
Branch:
N/A
Program / Phase / Year:
SBIR /
Phase I /
2015
Solicitation Number:
PHS2015-1
NOTE: The Solicitations and topics listed on this site are copies from the various SBIR agency solicitations and are not necessarily the latest and most up-to-date. For this reason, you should use the agency link listed below which will take you directly to the appropriate agency server where you can read the official version of this solicitation and download the appropriate forms and rules.
The official link for this solicitation is: http://sbir.nih.gov/sites/default/files/PHS2015-1.pdf
Release Date:
August 15, 2014
Open Date:
August 15, 2014
Application Due Date:
November 05, 2014
Close Date:
November 05, 2014
Available Funding Topics
- 007: Diagnostic Tools to Support the Elimination and Control of Neglected Tropical Diseases
- 007: Exploring the Potential of CRISPR/CAS Genome-editing Tools
- 009: Assay Development for High-Throughput Screening of Chemicals of Toxicological Concern
- 011: Development of Nanoparticle Dengue Diagnostic Tests
- 027: Thermostable Dry Vaccine Formulation for Microneedle Administration
- 029: Thermostable Oral Vaccines to Combat Enteric Diseases
- 029: Development of Novel Influenza Antivirals
- 030: Methods of Clinical Sample Preparation for Rapid Detection of Bacterial Pathogens
- 031: Inhaled Delivery of Clofazimine (CFZ) – An Important Anti-tuberculosis Drug
- 031: Simple, Inexpensive Unit for Removing Cells from Small Amounts of Blood in Resource-Limited Settings
- 032: Multiplex Assay for Simultaneous Detection of Hepatitis and Other Viruses
- 033: Improved Antibody Preparation for Post-Exposure Prophylaxis Against Hepatitis A
- 037: Optical Character Recognition Software for Scanning Nutrition Facts Panel
- 043: Yeast-derived Candidate of Hepatitis E Virus Vaccine
- 087: Transcatheter Cerclage Mitral Annuloplasty (SBIR-TT)
- 088: Closure Devices for Transcaval Access to the Abdominal Aorta
- 089: In-bore Defibrillation for Invasive MRI Cardiology Procedures
- 090: Devices to Close Ductus Arteriosus in Premature Infants
- 091: Therapeutic Delivery of ADP-ribosylarginine Hydrolase
- 092: Selective Silencing of Stat3 Signaling to Treat Relapsed Disease After Transplantation
- 093: Cellular Immunotherapy After Stem Cell Transplantation
- 157: Mobile Technologies Extending Reach of Primary Care for Substance-Use-Disorders
- 334: Vacutubes to Preserve the Viability of Circulating Tumor Cells
- 335: Development of Advanced Culture Systems for Expansion of Cancer Stem Cells
- 336: Development of Novel Therapeutic Agents That Target Cancer Stem Cells
- 337: Cell-Free Nucleic Acid-Based Assay Development for Cancer Diagnosis
- 338: Predictive Biomarkers of Adverse Reactions to Radiation Treatment
- 339: Systemic Targeted Radionuclide Therapy For Cancer Treatment
- 340: Validation of Mobile Technologies for Clinical Assessment, Monitoring, and Intervention
- 341: Simple and Robust Reaction Progress Analyzer
- 342: Online Real Time Metals Analysis at Low ppm Level
